Real-practice management and treatment of idiopathic multicentric Castleman disease with siltuximab: a collection of clinical experiencesBernardo Rossini, Attilio Guarini, Nicola Cecchi et al.|Drugs in Context|2014Cited by 3
Corrigendum: Real-practice management and treatment of idiopathic multicentric Castleman disease with siltuximab: a collection of clinical experiencesBernardo Rossini, Attilio Guarini, Giovanna Palumbo et al.|Drugs in Context|2024Cited by 3
Rethinking the feasibility and safety of venetoclax-obinutuzumab in chronic lymphocytic leukemia: non-traditional factors may play a role in clinical practiceAnna Maria Frustaci, Lara Crucitti, Andrea Galitzia et al.|Haematologica|2025Cited by 2
Real-World Venetoclax-Obinutuzumab in 232 Treatment Naive CLL Patients: Feasibility and TolerabilityAlessandra Tedeschi, Luca Laurenti, Andrea Galitzia et al.|Blood|2023Cited by 1